Cargando…
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
Hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is an aggressive tumor with a high mortality rate because of the limited systemic and locoregional treatment modalities. The development and progression of HCC depend on epigenetic changes that result in the activation or...
Autores principales: | Guo, Mengnan, Li, Ning, Zheng, Jianxia, Wang, Wei, Wu, Yan, Han, Xu, Guo, Jiapei, Chen, Weixi, Bai, Zekun, Bai, Wen, Wu, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169250/ https://www.ncbi.nlm.nih.gov/pubmed/34123955 http://dx.doi.org/10.1155/2021/5596712 |
Ejemplares similares
-
LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
por: Chen, Weixi, et al.
Publicado: (2023) -
Depletion and Reversal of Hepatocellular Carcinoma Inducing CTL through ER Stress-Dependent PERK-CHOP Signaling Pathway
por: Guo, Mengnan, et al.
Publicado: (2022) -
Zyxin promotes hepatocellular carcinoma progression via the activation of AKT/mTOR signaling pathway
por: CAI, TIANYING, et al.
Publicado: (2023) -
mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020) -
The mTOR signaling pathway in cardiac aging
por: Dai, Dao-Fu, et al.
Publicado: (2023)